Labcorp Holdings (LH) EBITDA (2009 - 2026)

Labcorp Holdings (LH) has 18 years of EBITDA data on file, last reported at $380.8 million in Q1 2026.

• Quarterly EBITDA rose 16.81% year-over-year to $380.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.4 billion (up 31.89% YoY) and the FY2025 annual result came in at $1.4 billion, up 27.42% from the prior year.
• EBITDA rose to $380.8 million in Q1 2026 per LH's latest filing, from $267.6 million in the prior quarter.
• The five-year high for EBITDA was $687.9 million in Q1 2022, with the low at -$122.8 million in Q4 2023.
• Average EBITDA over 5 years is $299.8 million, with a median of $321.3 million recorded in 2024.
• Year-over-year, EBITDA plunged 530.88% in 2023 and soared 276.3% in 2024.
• Labcorp Holdings' EBITDA stood at $28.5 million in 2022, then sank by 530.88% to -$122.8 million in 2023, then soared by 276.3% to $216.5 million in 2024, then climbed by 23.6% to $267.6 million in 2025, then soared by 42.3% to $380.8 million in 2026.
• Business Quant data shows LH's EBITDA at $380.8 million in Q1 2026, $267.6 million in Q4 2025, and $396.6 million in Q3 2025.